<SEC-DOCUMENT>0000950170-25-033071.txt : 20250305
<SEC-HEADER>0000950170-25-033071.hdr.sgml : 20250305
<ACCEPTANCE-DATETIME>20250305071508
ACCESSION NUMBER:		0000950170-25-033071
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250305
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250305
DATE AS OF CHANGE:		20250305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TScan Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001783328
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				825282075
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40603
		FILM NUMBER:		25708814

	BUSINESS ADDRESS:	
		STREET 1:		880 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		857-399-9500

	MAIL ADDRESS:	
		STREET 1:		880 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tcrx-20250305.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-04T16:54:30.5966+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:tcrx="http://www.tscan.com/20250305" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_d291a10e-2b1c-4ab9-b9cd-f845be9e0e90" name="dei:AmendmentFlag" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_93b02190-b0ff-4c56-8b69-93349406844e" name="dei:EntityCentralIndexKey" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d">0001783328</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tcrx-20250305.xsd"/></ix:references><ix:resources><xbrli:context id="C_7eb36c90-2bec-4080-b695-617c9e5c895d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-05</xbrli:startDate><xbrli:endDate>2025-03-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_078e0e57-8ead-4855-8a52-d60536c1d642" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:40.4%;box-sizing:content-box;"/>
    <td style="width:59.6%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">                                                               </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:0.02986111111111111in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_80d9a5e0-e4b4-46cf-9753-2e4f51b70664" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:24pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;"><ix:nonNumeric id="F_09300625-4434-4b6a-aa7e-4afa8e034710" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TSCAN THERAPEUTICS, INC.</span></ix:nonNumeric></span></p><p style="font-size:7.5pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:19.196%;box-sizing:content-box;"/>
    <td style="width:1.02%;box-sizing:content-box;"/>
    <td style="width:20.196%;box-sizing:content-box;"/>
    <td style="width:18.176%;box-sizing:content-box;"/>
    <td style="width:41.412%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1bca718d-897d-4ef3-9635-70cb5c9dc232" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6db9a875-c84a-4e2a-a899-662b4742106c" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-40603</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_15256d45-a01e-4e0d-a7fd-e071cedfdc84" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">82-5282075</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(State or other jurisdiction<br/>of incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1094ebb7-84a3-430a-b0cb-3e444acaad87" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">830 Winter Street</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_adf085f5-ea9b-419b-b3fa-d8708a9f533a" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Waltham</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_63f27d6e-16ac-4fd9-a5f6-12eb4b46a230" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e0b14f39-dfac-43be-b7f5-4c739611a0c0" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">02451</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:44.44%;box-sizing:content-box;"/>
    <td style="width:55.56%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.125in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:0.02986111111111111in;text-align:left;"><span><ix:nonNumeric id="F_5ac98563-bc87-427e-8fe1-6c3d4325fdee" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> 857</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_2b385c80-b306-437c-b24b-0393dc0ebe21" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">399-9500</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="border-top:0.5pt solid;padding-top:0.125in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Not Applicable</span></p><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Former name or former address, if changed since last report)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:6%;box-sizing:content-box;"/>
    <td style="width:3%;box-sizing:content-box;"/>
    <td style="width:91%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_c755d68b-1b9d-4a68-8901-d6df30ac6e9d" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_c759451f-6dfb-40be-b388-cd5301332e85" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_a483a9ef-0fe6-4a42-8353-59896ff717aa" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_8dca841a-ceb3-4807-957b-8e406bfcf40f" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:15%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_baa9cad6-e92c-4664-a9ec-fa0e9f11fb37" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Voting Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7c39a183-2a6a-471f-b138-20364eca7d56" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TCRX</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7770a869-77be-4fae-9559-389ef86fb4db" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Global Market, LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f0ca7d80-fe06-48b0-a83f-2f18a3f5d656" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a2c1f37b-1e41-4806-93f6-81c72b5695dc" contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 5, 2025, TScan Therapeutics, Inc. issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2024.  A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall neither be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings, unless expressly incorporated by specific reference in such filing.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Exhibits</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed:</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11%;box-sizing:content-box;"/>
    <td style="width:89%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tcrx-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release issued by TScan Therapeutics, Inc., dated March 5, 2025.</span></a></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6%;box-sizing:content-box;"/>
    <td style="width:44%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:46%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Gavin MacBeath</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gavin MacBeath, Ph.D<br/>Chief Executive Officer<br/>(Principal Executive Officer)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tcrx-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img207367504_0.jpg" alt="img207367504_0.jpg" style="width:175px;height:51px;"></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TScan Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Presented updated data from ongoing ALLOHA&#153; Phase 1 heme trial at the 66</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;"> ASH Annual Meeting and Exposition</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">IND application cleared for seventh TCR in PLEXI-T&#153; Phase 1 solid tumor program; TSC-202-A0201 targeting MAGE-A4 on HLA-A*02:01</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Closed $30 million registered direct offering at 37% premium with long-standing, supportive shareholder</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, and marketable securities continue to fund operations into the first quarter of 2027</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">WALTHAM, Mass., Mar. 5, 2025 -- </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today reported financial results for the three months and full year ended December 31, 2024, and provided a business update.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;The progress we achieved across our pipeline in 2024 has paved the way for a transformative year ahead. We are encouraged by the ALLOHA&#153; heme data presented at ASH with only 2 of 26 patients having relapsed compared to 4 of 12 control-arm subjects. We look forward to presenting additional data from the Phase 1 trial by the end of the year, including two-year relapse data on the initial patients,&#x201d; said Gavin MacBeath, Ph.D., Chief Executive Officer. &#x201c;For the PLEXI-T&#153; solid tumor program, we continue to enroll patients investigating seven different TCR-Ts, including the recently added MAGE-A4 TCR-T (TSC-202-A0201). We look forward to treating our first patient with multiplex therapy in the first half of 2025 and sharing safety and response data for multiplex therapy in the second half of the year.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Recent Corporate Highlights</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Company recently presented updated results from the ongoing ALLOHA trial of TSC-100 and TSC-101 at the 66</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Arial;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> American Society of Hematology (ASH) Annual Meeting and Exposition. </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Infusions with TSC-100 and TSC-101 were well-tolerated with no dose limiting toxicities and adverse events were consistent with hematopoietic cell transplantation (HCT). </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TSC-100 and TSC-101 TCR-T cells have been detected &gt;1 year post infusion and have a clear dose-persistence relationship.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2 of 26 (8%) treatment-arm subjects relapsed as compared to 4 of 12 (33%) control-arm subjects.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Median time to relapse was not evaluable in TCR-T-treated subjects vs 160 days in the control arm.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Event-free survival strongly favors the treatment arm (HR=0.30).</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In December 2024, the Company refinanced its previous convertible debt facility maturing in 2026 with a non-dilutive term loan for up to $52.5 million from Silicon Valley Bank (SVB), a division of First Citizens Bank, of which $32.5 million was drawn at closing. The SVB term loan allows for monthly interest-only payments through September 30, 2027, and matures on September 1, 2029.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In December 2024, the Company completed a $30 million registered direct offering with Lynx1 Capital Management LP (Lynx1), a large existing shareholder of the Company, and an investment fund advised by Lynx1, for pre-funded warrants to purchase up to 7,500,000 shares of the Company&#x2019;s voting common stock at a price of $4.00 per pre-funded warrant, representing a premium of 37% to the previous closing price of TScan Therapeutics&#x2019; common stock. Net proceeds from the offering extended the Company&#x2019;s cash runway into the first quarter of 2027.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Company announced that it has been named one of the </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Top Places to Work </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">in Massachusetts for the third consecutive year in the 17</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Arial;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> annual, employee-based survey from </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">The Boston Globe. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Top Places to Work</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> issue can be found online at Globe.com/TopPlaces.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Upcoming Anticipated Milestones</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Heme Malignancies Program: TScan&#x2019;s two lead TCR-T therapy candidates, TSC-100 and TSC-101, are designed to treat residual disease and prevent relapse in patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or myelodysplastic syndrome (MDS) undergoing allogeneic HCT (the ALLOHA trial, </font><font style="color:#467886;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">NCT05473910</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Opened expansion cohorts at dose level 3 to further characterize safety and evaluate translational and efficacy endpoints.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Plans to continue development of TSC-101 only, as TSC-101 enables treatment of ~98% of patients with HLA type A*02:01.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Initiate a registration trial for TSC-101, pending further feedback from regulatory authorities, in the second half of 2025.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Plans to present additional data from the Phase 1 trial by the end of the year, including two-year relapse data on the initial patients.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Plans to file an investigational new drug (IND) application for TSC-102-A0301, a TCR-T targeting CD45 on HLA-A*03:01, in the second half of 2025.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Solid Tumor Program: TScan continues to expand the ImmunoBank, a collection of TCR-T therapy candidates that target different cancer-associated antigens presented on diverse HLA types. TScan&#x2019;s strategy is to treat patients with multiple TCR-T therapy candidates to overcome tumor heterogeneity and resistance that may arise from either target or HLA loss (the PLEXI-T trial, </font><font style="color:#467886;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">NCT05973487</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">IND filing for TCR targeting MAGE-A4 on HLA-A*02:01 (TSC-202-A0201) recently cleared by U.S. Food and Drug Administration (FDA).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Company now has seven TCR-Ts cleared for clinical development in its PLEXI-T Phase 1 trial.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Progressing through initial dose levels across the TCR-T therapy candidates.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Plans to dose first patient with multiplex TCR-T therapy in the first half of 2025.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Safety and response data for multiplex TCR-T therapy anticipated in the second half of 2025.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Financial Results</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Revenue: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Revenue for the fourth quarter of 2024 was $0.7 million, compared to $7.2 million for the fourth quarter of 2023, and $2.8 million for the full-year 2024, compared to $21.0 million for the full-year 2023. The decrease in both periods was primarily due to timing of research activities pursuant to the Company&#x2019;s collaboration</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">agreement with Amgen which commenced in May 2023 compared to the collaboration and license agreement with Novartis which ended in March 2023.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">R&amp;D Expenses: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Research and development (R&amp;D) expenses for the fourth quarter of 2024 were $29.4 million, compared to $22.4 million for the fourth quarter of 2023, and $107.4 million for the full-year 2024, compared to $88.2 million for the full-year 2023. The period over period increases were primarily driven by an increase in clinical studies expense associated with the ongoing enrollment of our ALLOHA Phase 1 heme trial and start-up activities and initial enrollment in our PLEXI-T Phase 1 solid tumor clinical trial, as well as an increase in personnel expenses due to additional headcount in support of our expanded research and development activities. R&amp;D expenses included non-cash stock compensation expense of $1.3 million and $0.9 million for the fourth quarter of 2024 and 2023, respectively, and $4.8 million and $2.9 million for the full-year 2024 and 2023, respectively.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">G&amp;A Expenses:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> General and administrative (G&amp;A) expenses for the fourth quarter of 2024 were $8.0 million, compared to $6.2 million for the fourth quarter of 2023, and $30.3 million for the full-year 2024, compared to $26.4 million for the full-year 2023. The period over period increases were primarily driven by an increase in personnel expenses due to increased headcount to support business activities. G&amp;A expenses included non-cash stock compensation expense of $1.4 million and $0.6 million for the fourth quarter of 2024 and 2023, respectively, and $4.7 million and $2.3 million for the full-year 2024 and 2023, respectively.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Net Loss: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Net loss was $35.8 million for the fourth quarter of 2024, compared to $19.6 million for the fourth quarter of 2023, and included net interest income of $2.0 million and $1.7 million, respectively. Net loss for the full-year 2024 was $127.5 million, compared to $89.2 million for the full-year 2023, and included net interest income of $8.4 million and $4.2 million, respectively. Net loss for the fourth quarter of 2024 and full-year 2024 included a $1.1 million loss on extinguishment of debt.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Cash Position: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, and marketable securities as of December 31, 2024 were $290.1 million, excluding $5.0 million of restricted cash. The Company believes that its existing cash resources will be sufficient to fund its current operating plan into the first quarter of 2027.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Share Count:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> As of December 31, 2024, the Company had issued and outstanding shares of 56,590,627, which consists of 52,314,039 shares of voting common stock and 4,276,588 shares of non-voting common stock, and outstanding pre-funded warrants to purchase 73,087,945 shares of voting common stock at an exercise price of $0.0001 per share.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">About TScan Therapeutics, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TScan is a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer. The Company&#x2019;s lead TCR-T therapy candidates are in development for the treatment of patients with hematologic malignancies to prevent relapse following allogeneic hematopoietic cell transplantation (the ALLOHA</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#153;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> Phase 1 heme trial). The Company has developed and continues to expand its ImmunoBank, the Company&#x2019;s repository of therapeutic TCRs that recognize diverse targets and are associated with multiple HLA types, to provide customized multiplex TCR-T therapies for patients with a variety of cancers (the PLEXI-T</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#153;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> Phase 1 solid tumor trial). The Company is currently enrolling patients into both clinical programs.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, express or implied statements regarding the Company&#x2019;s plans, progress, expectations, and timing relating to the Company&#x2019;s hematologic malignancies program, including clinical updates of the ALLOHA Phase 1 heme trial, presentation of data, opening of expansion cohorts, filing of an IND for TSC-102-A0301, and initiation of registrational trials; the Company&#x2019;s plans, progress, expectations, and timing relating to the Company&#x2019;s solid tumor program, including clinical updates of the PLEXI-T Phase 1 solid tumor trial,</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">enrolling and dosing patients, and presentation of data; the progress of the hematologic malignancies and solid tumor programs being indicative or predictive of the success of each program; the Company&#x2019;s current and future research and development plans or expectations; the structure, timing and success of the Company&#x2019;s planned preclinical development, submission of INDs, and clinical trials; the potential benefits of any of the Company&#x2019;s proprietary platforms, multiplexing, or current or future product candidates in treating patients; the Company&#x2019;s ability to fund its operating plan into the first quarter of 2027 with its existing cash, cash equivalents, and marketable securities; and the Company&#x2019;s goals, strategy and anticipated financial performance. TScan intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as, but not limited to, &#x201c;may,&#x201d; &#x201c;might,&#x201d; &#x201c;will,&#x201d; &#x201c;objective,&#x201d; &#x201c;intend,&#x201d; &#x201c;should,&#x201d; &#x201c;could,&#x201d; &#x201c;can,&#x201d; &#x201c;would,&#x201d; &#x201c;expect,&#x201d; &#x201c;believe,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;project,&#x201d; &#x201c;target,&#x201d; &#x201c;design,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;potential,&#x201d; &#x201c;plan,&#x201d; &#x201c;on track,&#x201d; or similar expressions or the negative of those terms. Such forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions, and uncertainties. The express or implied forward-looking statements included in this release are only predictions and are subject to a number of risks, uncertainties and assumptions, including, without limitation: the beneficial characteristics, safety, efficacy, therapeutic effects and potential advantages of TScan&#x2019;s TCR-T therapy product candidates; TScan&#x2019;s expectations regarding its preclinical studies being predictive of clinical trial results; TScan&#x2019;s approved INDs being indicative or predictive of bringing TScan closer to its goal of providing customized TCR-T therapies to treat patients with cancer; the timing of the launch, initiation, progress, expected results and announcements of TScan&#x2019;s preclinical studies, clinical trials and its research and development programs; TScan&#x2019;s ability to enroll patients for its clinical trials within its expected timeline; TScan&#x2019;s plans relating to developing and commercializing its TCR-T therapy product candidates, if approved, including sales strategy; estimates of the size of the addressable market for TScan&#x2019;s TCR-T therapy product candidates; TScan&#x2019;s manufacturing capabilities and the scalable nature of its manufacturing process; TScan&#x2019;s estimates regarding expenses, future milestone payments and revenue, capital requirements and needs for additional financing; TScan&#x2019;s expectations regarding competition; TScan&#x2019;s anticipated growth strategies; TScan&#x2019;s ability to attract or retain key personnel; TScan&#x2019;s ability to establish and maintain development partnerships and collaborations; TScan&#x2019;s expectations regarding federal, state and foreign regulatory requirements; TScan&#x2019;s ability to obtain and maintain intellectual property protection for its proprietary platform technology and our product candidates; the sufficiency of TScan&#x2019;s existing capital resources to fund its future operating expenses and capital expenditure requirements; and other factors that are described in the &#x201c;Risk Factors&#x201d; and &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; sections of TScan&#x2019;s most recent Annual Report on Form 10-K and any other filings that TScan has made or may make with the SEC in the future. Any forward-looking statements contained in this release represent TScan&#x2019;s views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Except as required by law, TScan explicitly disclaims any obligation to update any forward-looking statements.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Contacts</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Heather Savelle<br>TScan Therapeutics, Inc.<br>VP, Investor Relations<br>857-399-9840<br> </font><font style="color:#467886;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">hsavelle@tscan.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Maghan Meyers<br>Argot Partners<br>212-600-1902<br> </font><font style="color:#467886;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TScan@argotpartners.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67.313%;box-sizing:content-box;"></td>
    <td style="width:1.5%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:12.843%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.5%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:12.843%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="8" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="8" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Condensed Consolidated Balance Sheet Data</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="8" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">(unaudited, in thousands, except share amount)</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">December 31, 2024</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">December 31, 2023</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Assets</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">178,689</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">133,359</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Other assets</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">192,429</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">138,790</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Total assets</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">371,118</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">272,149</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Liabilities and Stockholders' Equity</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total liabilities</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">130,148</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">121,282</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total stockholders' equity</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">240,970</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">150,867</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders' deficit</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">371,118</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">272,149</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:35pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Common stock and pre-funded warrants outstanding </font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(1)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">129,678,572</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">94,840,055</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:35pt;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td colspan="8" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(1)</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;Includes at December 31, 2024 and 2023, respectively, 73,087,945 and 47,010,526 issued and outstanding pre-funded warrants to purchase shares of voting common stock at an exercise price of $0.0001 per share.</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td colspan="8" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.761%;box-sizing:content-box;"></td>
    <td style="width:1.121%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.189%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.121%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.189%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.121%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.189%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.121%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.189%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="16" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="16" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statements of Operations</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="16" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">(unaudited, in thousands, except share and per share amounts)</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Three Months Ended December 31,</font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Twelve Months Ended December 31,</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2024</font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2023</font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2024</font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2023</font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Revenue:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Collaboration and license revenue</font></p></td>
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">665</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">7,211</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">2,816</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">21,049</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Operating expenses:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Research and development</font></p></td>
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">29,354</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">22,407</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">107,350</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">88,153</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">General and administrative</font></p></td>
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">8,023</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">6,161</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">30,287</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">26,354</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:28pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5.187%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total operating expenses</font></p></td>
    <td style="padding-top:0.01in;text-indent:28pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5.187%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">37,377</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;text-indent:28pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5.187%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">28,568</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">137,637</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;text-indent:28pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5.187%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">114,507</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Loss from operations</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(36,712</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(21,357</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(134,821</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(93,458</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Interest and other income, net</font></p></td>
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">2,777</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">2,596</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">12,065</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">7,999</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Interest expense</font></p></td>
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(784</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(852</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(3,653</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(3,759</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</font></p></td>
    <td style="padding-top:0.01in;text-indent:14pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:2.587%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(1,090</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">-</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(1,090</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">-</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Net loss</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(35,809</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(19,613</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(127,499</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(89,218</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(0.30</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(0.21</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(1.14</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(1.36</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Weighted average common shares outstanding&#x2014;basic and diluted </font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(2)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">120,789,625</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">94,835,735</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">111,990,417</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">65,599,858</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td colspan="16" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(2)</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;The calculation of weighted average common shares outstanding-basic and diluted includes 73,087,945 shares of the Company's voting common stock issuable upon exercise of pre-funded warrants for the three and twelve months ended December 31, 2024, and includes 47,010,526 shares of the Company's voting common stock issuable upon exercise of pre-funded warrants for the three and twelve months ended December 31, 2023.</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td colspan="16" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td colspan="16" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img207367504_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img207367504_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %1!(,# 2(  A$! Q$!_\0
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MV%V[CM-=#HGQ%^'_ (FF6W\.>.O!VOSN 4@T3Q-HFJS,&P5*QV-].[!@R[<
MYW#\-I8;$QCSSP]>,;7<I4IJ*]6XV_$5UW7WH[*BBBL!A1110 4444 %%%%
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M6:?0-?M&-GKV@7C !OM&DZI%<6ZS,D2WEJMKJ$*"VO(&;VBOYA?^"3'[4O\
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M]_KOBCQ5K.G>'O#VC6,9 DO-5UG5[FTT[3[5"RAKBZN(8E+*"_(K\!/VJ_\
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M=HX[SQS\"M:&KV*M(P0RO\.O'-[9WUG:0',TLT'Q$UFZ:'>D%A--&B3?T/\
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MMC,VE>/)A)%XQ-L&DNI+'Q];ZEJFI2+#91>,-$M?GC_LQ_9$_;G_ &:/VX_
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M%//^CP?B1_X+_!7_ ,RU?F/11_JIPO\ ]$WD'_AFR[_YF_J[\K'M*G_/R?\
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M_P"9!]EMO^?>#_OS'_\ $T?9;;_GW@_[\Q__ !-3T47?=_U_PR^X.>?\TO\
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M]ZRC3KTU[>DHVJTJ/L4*ZK1O:TU;FC^J\G\[=>C?H%%%%?GQN%%%% !1110
M5_)=_P '5?\ R(/[%_\ V-_QL_\ 3+\-J_K1K^2[_@ZK_P"1!_8O_P"QO^-G
M_IE^&U?H_A'_ ,G$X;_Z^YA_ZJ,P.?%?[O4_[<_]+B?QH4445_=)XX4444 ?
MZ0'_  03_P"43G[*7_==/_6D_C%11_P03_Y1.?LI?]UT_P#6D_C%17^>O&O_
M "67%O\ V4V??^K7%GMT/X%'_KU3_P#2(G[ 4445\R:G+>-/%_AWX?>$O$GC
MCQ;J4>D>&O"FBZAK^MZC-]VUTW2[:2ZNG51\TTS1Q>7;V\>Z:ZN&AMX%DFFB
M1OXL/VE/CKXA_:0^,WC+XL>(?-MUUV_:W\/:/)*)$\.^%-/9K;P_H4>T^5NL
M[ +)?30K''?:O<7^I;$DO)#7[!_\%AOVI2JZ5^RUX.U'EQIOBKXLS6LW1?W=
M_P"$?!T^T\[B(/%NJ02(247PP\,AWW<-?@)7Z/PGE?L,/+'UDO;8F*5%-:PP
MZ:DI=-:TDIZ63A&#7Q,_TY^A_P"%7^KG#5;Q#SC#<F<\5T(T<EA5A:I@N&HU
M(U(UHII.$\ZQ%.&)^TI8##8"I3DEB*L64445]B?V>%%%% !1110!]Y?LU_\
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M (?0_M4?]"7\"/\ PE/'?_SS*_(RBC^PLH_Z ,/_ . _\'^KORL?\0!\&O\
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M45]1_864?] &'_\  ?\ @_U=^5OZI_X@#X-?]&[X<_\ ":KY?]/_ "_'UO\
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M8U-?W<L10J45/37W7-2T[#B[2B[7M).SUO9IG^O/17P'_P $Y_V]_AG_ ,%
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M-4K*GW83#J5JM1:)^Y%K=JSYG?HFM+73:OT0BJJ*$0!54!550 % & J@8
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M+?BU)97!2[T+X;0WL,D<.CK+')9ZQX^NK>YTJRN%FTW1+;6]7MM3AT;^Q?\
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MGP3_ ,B9X1_[%C0/_35:5T]<QX)_Y$SPC_V+&@?^FJTKIZ_"9_'+_%+\V?X
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M_"GQ.%BMKGXK_#/3M3\5?#B_< !]0UKP:LFH>.O"A8_>M]#_ .$_CFDWS?\
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M?^"='[)>H_ML?MA?!SX"QP73>%M9\0)XC^)NH6K21G2/AAX4VZSXTN?M4?\
MQXW6HZ;!_P ([HMTQVIXBUS1X?\ EL$K_42TO2]/T33-/T71[&UTS2=(L;33
M-+TVQ@CMK+3M.L+>*TL;&SMH56*WM+2VBCM[>&-$CAAC1%0*H%?SIX^<4/#X
M++^%,-.U3'RAF69<LM8X.A4<<%0FEHUB,5&=>VZ>#I2^&H=V"IWE*J]HWC'S
M;^)_):?-G\V7_!RC^QM_PMG]F_PE^UCX1TG[1XV_9SOQHWCA[6'==ZG\'O&6
MHV]I+<3^6K3W0\$^,9M,U*UC55AT_1O$GC#5+ATA@>OX7*_UTO'O@?PO\3O
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MWVIXF^(>N.NC>!O#WEHZW$MO?^([VP;5VM1)-8Z#;ZKJIC\BPF=/K>OXBO\
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MK-YX?\4^%]=MOLFJ:/J]A)LGMKB(EDE1AMFM;JWDFL[ZSFAO["YN;.YAF?\
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M_5\;AFVH8BA)]'9QJ4VW.C44J<_>5W[-*I&K%2CZ-=4^S_K4*_DN_P"#JO\
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ML\L<$$<DTTTB1111(TDLLLC!(XXXT#2/*\C*JJJLS,VQ/>*OUC_X)0_LM?\
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M@/\ @@G_ ,HG/V4O^ZZ?^M)_&*BC_@@G_P HG/V4O^ZZ?^M)_&*BO\]>-?\
MDLN+?^RFS[_U:XL]NA_ H_\ 7JG_ .D1/V K\(?^"PO[+0U+3-*_:B\&Z?NO
MM&33_"WQ6BM8LO<Z2\B6?A7Q;,$ W2:7<R1^&=4N&,D[V=[X= \NUTJX:OW>
MKGO%/AG0O&?AO7O"'B?3K;6/#GB?2-0T+6]+N@6M[_2=6M)K*^M90NTJ)K>:
M1?,C*R1D[XW1U5AX^6X^IEN,HXJG=J$N6K"_\2E)KG@_5).-](SC&3^$_1O"
M[C_,/#/C?)>+<#[2I3P=?V&:X*$N59EDV*E"GF.!E=J#G4H_O<+*HI1HXVCA
ML1RMT4G_  845]$?M3? #7?V:/C9XP^%>L&XNK'3KK^T_".LSHJ?\)#X,U1Y
M9- U<%56)KDP)+I^J+#^XM]:T[4[-';[,7/SO7[+1K4\12IUJ4E.G5A&I"2V
M<9I23\G9JZ>J=TTC_;7)\WR_/LJR[.\IQ-/&99FN"PV88#%4VW"OA<72C6HU
M$FDXMPFN:$K3A-2A-1G&444445J>D%%%% !1110 4444 %%%% !1110!_>3X
M)_Y$SPC_ -BQH'_IJM*Z>N8\$_\ (F>$?^Q8T#_TU6E=/7X3/XY?XI?FS_ '
M'?[[C/\ L*Q'_IZ84445)RGQG_P4+_Y,P^/_ /V)]M_ZD6B5_&W7]DG_  4+
M_P"3,/C_ /\ 8GVW_J1:)7\;=?I'!G_(OQ7_ &&/_P!,43_3GZ$7_)NN*?\
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M2BO<IS52$9K[2O;L^J^3T"BBBO#+"BBB@ HHHH **** "BBB@ HHHH ****
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M ,$:K3]J'2-<_:I_9C\.06G[2&@Z<;SX@> ])@C@B^.FB:; %^V:?;Q;(_\
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MX;@,^J^)?$U^EE9HQ5V@L+*'#WFKZS?LC0Z7H6DVM]K.K712STVPO+ITA?\
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M?K"E']QAT^6FISYZ]7U*&'C15_BFUK+MW4;[+SW?4****_-3I"BBB@ HHHH
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MLK;4M(UG1]4M9;'4M+U33KR.:TO]/O[.::UO+.ZAEM[FVFDAFC>-W2OX"?\
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M]_#_ ,(-?\32*.,E8]1\=>$U<C' ,B;O[Z43\5_#ZG%REQ)AFETIX7,JK_\
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M ."%_P#P3*^#TUI?P?L[6OQ)UJTVXU;XP>)_$OQ!AN-A!'VOPIJ.HP^ )]S
M.X;PB WW#\GR5X&8>.G!.$C+ZI_:N:3UY5A<%["#?3FGCZF$E&+VNJ4Y?W"X
MX.LWKRQ7FT_PC?\ ,_SPOA9\%?B_\<O$47A+X-?"_P ?_%/Q+(8E;1? 'A+7
M?%=_ DS%$N+V'1;*\-A9@AFFOKS[/9V\<;S3SI"CR)^_G[)W_!M9^U=\59],
M\0_M.>*O#?[-W@R7RKBX\.6DUA\0_BO>VY991 NE:)?'P;X>^U0?+]KU3Q5J
M&J:7,X^V>%9I(9;:O[BO!7@+P-\-]"MO"WP[\&>$_ 7ABR)-GX<\%^'='\+:
M#:%E52;;1]#L['3[<LJJK>5;ID*N>, =;7Y;G_CUG^.C.AD6 PN2TW>*Q5:2
MS'')65I4W4IT\)1;W<9X;$.+MRU-+OHIX&$;.<G.R^%>ZNFE_B>W=7Z]$OSX
M_8R_X)@?L=?L+6-M/\%_AE;7OQ!2T-KJ/QB\>O;^+/BCJ0EB,-TL&OSV=M9^
M%[2\B/EWFD^"=+\-:1>*J/>:?<S S-^@]%%?BF89CC\UQ53&YEC,3CL75?[S
M$8JM.M5DDVU'FFVXPC=J$(VA!>["*6AV1C&"48Q44MDE9?A^84445Q%!1110
M 4444 %0W%Q!:P3W-S-%:VUM%)/<7$\B0P000H9)9II9"L<444:L\DCLJQJI
M9B%!-35POQ-^'V@?%CX>>-_ACXKDU:/PQ\0?"VN>#O$G]A:O>Z#K$F@^(M/G
MTK5[;3]:TV2'4=+GNK"ZN+87UC-#>6ZS,]K-#,$D2H*#J4XU)2A3<XJI.$/:
M2A3<DISC!R@IRC%N482G!2:2YENA[.VKZ+:Y_FJ?\%6?VR9_VX/VT_BC\5]-
MU"6[^&WAZZ'PU^#<)9_L\?PV\'75Y;:;JMO$_P T)\9ZM<:SXXN(7_>6\_B1
M[-W"6<*1_G)7^B)_Q#R?\$O?^B2^//\ P\?Q%_\ EW1_Q#R?\$O?^B2^//\
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MY1<IXB5X+V<7+JPV'=%RE.SD[)6;=EI?5I:MVOZ>84445^-'6%%%% !1110
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MY/\ @E[_ -$E\>?^'C^(O_R[H_XAY/\ @E[_ -$E\>?^'C^(O_R[KS\U\:>
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M5Y=\9_@Q\,OVA?ACXO\ @Y\8O".E^./AUXZTN32?$7A[58W\J>$NDUK>6=U
M\5YI>L:7>16^I:+K6FW%IJFC:I:VFI:;=6UY:PS)]_X?\>YAP/F2G'VF*R?%
MSA',\N4OCBK16*PO-)1IXRC'X6_=KTU["LTG3J4L*]"-:-MI+X9?C9^3^];K
MS_R4**_T1/\ B'D_X)>_]$E\>?\ AX_B+_\ +NC_ (AY/^"7O_1)?'G_ (>/
MXB__ "[K^A?^(]\%_P#0)Q!_X18+_P">7K_3TX?J5;O#_P "?_R)WG_!!/\
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ME]6S;BZ=*?V?<Q&3Y-4M9^\^3-L53DD[+*VFU*K ****^$/\^0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?]##!_\ A1#R\_/\/6Q_Q&SPB_Z.1P;_ .'[+_\ Y<?F917Z9_\ #I']LO\
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M  Z1_;+_ .A:\$?^%[HW^%']LY5_T,,'_P"%$/+S\_P];'_$;/"+_HY'!O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+2[;6_!^O2ID!Q!JD>IZ[I,1*_=$GAN;YSG?LP@_;G]EO]L#X2?M8^&KO5?
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M_M2ZY\7;#XL7WAV\@\&Z3X/O-#&AZ!;Z*T<^M7?B&&^-R8)9?M"M'IUKY:L
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MWPZ9JEYK7AHL#RK3:%+D@!MZ_+1_;7#-1^SJ91R0=ESQPF$C);*[=.<9J_\
M=G)]D^@_'+Z+.93> QW@LL%@)OV<<=A^$.$</B*<'9<]2>69A0QU)6UE+#XB
MO6O=Q4I.[[?]B3]KN/\ ;!^'OB'Q<W@A_ NI^%/$$/AO5M.76QKUA>W$NF6V
MI+>Z?=G3=,GA@D6XVM:7-M));D&/[5<C][7VI7QK^QU^R+IW[(6@_$'PIHGC
M.]\9:'XO\66WB72Y=4TJ#3=4TJWBTBWTUM.U"6TNI;34YE:V\Y=0@M=,619
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MZ"L#DN0X/#U<QH+%8BLDFITU6<I\L93A2I3M1C"FG;FD^9WNY7M%?Z1T> /
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MYMBJRIU'&K3HQ]O&CA:G[!T445^<G^8P4444 %%%% !1110!PWQ)\>:)\+O
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M#YS2J4:DJ<Z6'P\X2BW=2C.I).SNM]U:S5TUJS]I^EEGF;\/>-^4YKDV88G
M8[+.'.'<?@JU"K*/L<5ALPS.K2J<EW":YH14X5(SA5A>G4C.G)Q?\+&NZ-\1
M/@)\4[S1]0&H>#?B5\,/%:*)K>0QWFCZ_H5Y'<V.HV%R!LG@:2.WO]-O(_-M
M=0L9K6YA\ZVN$W_UV?L7?M1Z)^U7\&-)\:1-:6?C?1#!H/Q'\.V[[3I7B:&!
M2U]:V[LTJ:%XBA7^U]%D+2I'%+=:4]S->Z5?[/AK_@K'^Q\/B'X0;]H_X?Z5
MYGC7P#I@A^(5A91 S^)? =D&9=>*1C=/JG@Q#))<R,IDN/##W0EG*:!IML_X
MS?L8?M1:Y^RG\9M)\;0M=WO@K6?)T#XD^'8&W#5_#$\ZL][:P,RQ-KGA^8_V
MMHLC/&\DD=SI+W,%GJE_O]C$TZ7$^4PQ-&,8X_#1E[BLG[5*+J8=_P!RM\=&
M3=E)Q3DOWB7[3Q5EF4_2J\&L%Q3D5##T/$+AB%6+P5-J-2&:4J-.IFF03<VW
M]0SBFJ6.R6K5E:C7>%C.M2OF,#^SFBL/PWXCT/Q?X?T3Q5X9U.TUKP]XCTNQ
MUK0]6L9?-L]2TK4K:*[LKRWDP&,5Q;RQ2+N577.R14DW(-ROSQIIM234DVI)
MZ--;IIV::ZII,_S3JTJM&I4HUJ=2C6I3G2JTJL)4ZM*K3DX5*=2$DI0J0DG&
M<))2C)--)IA1112("BBB@ HHKXT_;X^./_"@OV8?B)XKL;O['XI\0V8\!>"G
M63RKA/$GBV&>R%]9L#Q=:#HR:OXDAX96DT?8ZD/@[8>A/$UZ.'IJ]2M4A2AV
MO.2BF_)7NWT2;/:X<R+'\49_DW#F60]IF&>9G@LKPB:;C&MC<13H1J5&OAHT
M>=U:TW:,*4)SDU&+:_FB_;U^.7_"_OVG_B+XML;S[9X6T"]'@/P2Z2>9;-X9
M\)RSV27MHP)S:Z]J[ZQXDA^ZP76"CHFSGTWX<?\ !+O]J?XH> O"?Q$\/V'@
M>ST'QGHEAXBT6'7?%$NG:HVDZI$MSIMU<V2Z5<" 7]F\-Y;IYS.UK<0R/L9]
MD?RG^SO\)+[X[?&[X:?">Q$P'C+Q186.JW$ S+8>';0OJ7B?4TX/S:9X=LM4
MOHPPVM);HN]-]?V[Z;I]AH^G6&DZ7:PV&EZ596NGZ=96Z^7;VEA901VUI:01
MCA(;>"**&- #B-5 /K^@YUFD\BI8' X%4N>-)<RJ1<^6C34*=.Z4H^]4G&3<
MM5>$GU9_I%XY^+>-\ ,FX X$X I98\90RB*K1S3#3Q<:&29;1I9=@:LJ-+$8
M>^)S/%TL75J5W.3=3!8AR4I5N<_EI_X<_P#[7_\ SR^&/_A;3?\ RCKQ[XZ_
M\$[OVC/V>?AWJ'Q0\>V/A*?PII-_IEAJD_AOQ$^KW=@=8O$T^RN[FV?3K-4L
M7U":UL6F$C,MU>6R!,2;T_L'KS3XP_#71_C%\+?'_P +M="#3?'/A;5_#SW#
M1B4Z?=7MK(-.U6&,\&ZTC4EL]4M?[MU9POC(Q7B4.+LQ5:C[=8=T/:0550HN
M,_9\T>=Q?.TI**;BW%KFMTT/P?(?IE^)$<[RC^WZ'#53(GF6"6<PP>4XFCBW
ME;Q%...>%J?VA54,1##.I*BW2J1]I&"E"2;1_-3_ ,$E/CC_ ,*R_:1_X5[J
MMX+?PQ\:]*'AEUEEV6\7C'1_M6J>#[I\GYY+DOK/ARUC"[GN_$-J=^R.OZH:
M_A#N(/%GPG^(,UO(9] \<_#;QB\3.AQ<Z+XK\'ZT5W(2!B;3M7T[<K;?]9#W
M'-?VP? GXJZ5\</@_P##OXKZ.(H[7QMX7TW5[BUA<RIINK[6M-?T?>2S-)HV
MNVVI:3(VYLR6;G.:UXOPBC7P^84TG#$P5*I*.J=2G%.G-RV;G2]U6>U%_/V?
MIG\%4\-GW#OB/EL(3P/$^"IY5F>(HVG2GF>7T%5RW%2JKW9RS#)VJ-)P;C[+
M*')?%>7KE%%%?''\1!1110 4444 ?./[87_)J7[2'_9$?B;_ .HAJU?QZ_ G
M2=,U_P".'P;T+6K&UU/1M:^*OP\TK5M-O(UFM-0TS4O%VCV=_8W4#926VNK6
M::WFC8[9(Y'3VK^PK]L+_DU+]I#_ +(C\3?_ %$-6K^0/]G'_DX7X#_]EF^%
M_P#ZF^AU]YPHVLMS-IV:E*2?9JA=-6LT^S3NNFI_HA]$"<Z?A?XI5*<Y4ZD,
M;7E"<).$X37#[<9PFK2C*+2<91:::33329_7)_PQ#^R+_P!&[?"G_P )/3__
M (BNL\*_LN_LW>"+Z'4O"OP)^$VB:G;N)(-4M? ?ALZI;.IW*]KJ<VG2WUN5
M/'[FXC^[T^6O>J*^+EC,7-.,\5B91:LXRKU9)I]TY-/;JC^%,1QGQABJ4\/B
MN+.)<30J1<:E'$9]FM:E4BU9QG3J8N4)1:T<9)IINZ=V%%%%<Y\T%%%% !11
M10 4444 ?(7[?/\ R9Q^T'_V(%Y_Z76%?RP_L:_\G8_LX_\ 99_AY_ZDVG5_
M4]^WS_R9Q^T'_P!B!>?^EUA7\;^C:UK'AS5M-U_P]JVI:#KNC7MOJ6D:UHU_
M=:7JVE:C9RK/:7^FZC8RP7MC>VLR+-;W5K-'-#*J/"Z.E?H/"E-U<KS"DFHN
MK5JTTW>R<\-3BF[=$W=^6I_H_P#1 RZ>;^$7B-E%*I"C5S3.\TRZG6J)RA2G
MC>&<!AHU)QC[SA"552DHZM)I--H_O=HK^(W_ (:O_:E_Z.4^/W_AX_B)_P#-
M'1_PU?\ M2_]'*?'[_P\?Q$_^:.N'_4S%?\ 091_\%S\O/S_  ];?!_\2.\5
M_P#1<\/_ /ANS'R_O>;^[S/[<J*_G*_X)-?'#XT?$;]I;Q'H/Q#^+_Q0\>:)
M;_!_Q3J<&C>,_'_BSQ1I,&I0>*_ UO!J$6G:YJM_9Q7T%O=W5O#=K"+B.*ZN
M84=$F='_ *-:^<S/+YY9BY82I4C5DH0J<\%)1:FFTO>UNK:G\R>*OAOCO"KB
MN?"F89EA,UQ$,OP68/%X.E6HT7#&JI*%/DKWGSP5-\SO9W5MF%%%%>>?FX44
M44 %%%% 'XC_ /!:OX9WVL_#;X1_%:PMGFM_ WB;7?"NO/$I8P6'C>TTRYTV
M]N<<1VMMJ?A<:>)#M'VO6K>'[TR5\._\$FOVA_"WP8^-_B/P9XXU:ST#PS\8
M=%TO1[;6M0G2UTVR\8^'[VZN/#,6I74S)!9V>I6VL:]IL=S,RQQZE=Z;"^R&
M:::'^E[XE_#KPG\6_ 7BKX;>.-.&J^%?&.D3Z1J]H&$<ODRD207=G,4<VNHZ
M;>1V^I:9>!6>RU&UM;E/GA0U_)?^U;^P5\:?V8M=U2ZFT/4_&WPL$\TNB_$K
M0=.FN].CT_>3!#XLMK43R^%M5AC*QW"ZAMTNZFW_ -EZE>(C^3]QD6*PF/RN
MKD>*J*E-\\:+;4>>$ZD:L73<M)5*5:\O9NSE&W*FE*W]\_1]XLX/\0_"?-_
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MQLL;EN#G@(YMAL'4JX=YMEN9X*7/F6'PM6G/"8QKG]DJ.#JU_P"X&D)"@DD
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M+O\ D7XOUK?^FJ1^N^&__)L^,/\ K[G_ /ZH< ?LI1117@'\\!1110 4444
M%<IX\_Y$?QG_ -BIXB_]-%Y115T_XE/_ !Q_]*1UX#_?L%_V%X;_ -/0/PRH
MHHK[T_O4*^@OV6O^2Y>#/^N?B7_U%-<HHKEQO^ZXC_L'K?\ I!\_Q;_R2G$_
M_9/YQ_Z@5S]=J***^)/X?"BBB@ HHHH *^2OVS?^24:7_P!COI'_ *9_$-%%
M=6"_WO#_ /7Q?J?7<!?\EEP[_P!C*C^4CY=_9"_Y+%;_ /8N:Y_Z!;5^J]%%
M=><_[Y_W"I_G(^I\9/\ DKX?]BC!?^GL68OB3_D7=?\ ^P+JO_I#/7X0T45V
MY%\&)_Q4ORF?8>!O^[<1_P#7_+/_ $WC3]COV=?^2*_#_P#[!-Q_Z=+^O:J*
M*\/$?[Q7_P"OU7_TN1^)\3?\E'Q!_P!CO-?_ %/Q 4445B>(%%%% !7QA^VQ
M_P B)X2_[&T_^F?4:**[<N_WW#_XW_Z3(^U\.O\ DMN'O^PV7_J/7/FG]DW_
M )+3H?\ V"O$'_IJN*_66BBNC./]ZC_UXI_G,^G\:?\ DK<-_P!B/!?^I6/"
MBBBO*/R,_%;XU?\ )6_B-_V-^M_^ELM?H[^RE_R1+PU_U_>(O_3]J%%%?19G
M_P B_#_XJ/\ Z8/Z0\3/^3<\._\ 81DG_JHQ9]&4445\Z?S>%%%% !1110!Y
MQ\8?^24?$C_L2/$__IGNZ_('X<?\E#\!_P#8Y^%__3Y8T45]!E/^ZXG_ !/_
M -(@?T/X0?\ )+\5?]?9_P#J ?N+1117SY_/ 4444 %%%% !1110 4444 >0
M?'W_ )(W\0?^P!+_ .E%O7XS445]-DG^[UO^OW_MD#^F/!+_ )$&;?\ 8X?_
M *A84****]H_:#ZU_8R_Y*OJG_8D:O\ ^GCP]7ZAT45\EFW^]O\ Z]4O_23^
M4O&'_DLJG_8LR_\ ])J!1117F'Y8%%%% !1110 5'-_JI?\ KF__ *":**!Q
MW7JOS/X[OVYO^2N:Y_V%;G_V>OTJ_P""1G_(3O\ _L&77_HJ2BBOTG,O^2;C
M_P!>(?G _P!2/%7_ )1II_\ 8DPG_IND?O71117YL?Y;!1110 4444 %%%%
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=*G^"'Y'ROTK_ /D[^:?]B_ ?E6"BBBOGC^:S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>tcrx-20250305.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-04T16:54:27.9147+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.tscan.com/20250305" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:tcrx="http://www.tscan.com/20250305" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="tcrx-20250305.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45656643005648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 05, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001783328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  05,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TSCAN THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-5282075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">830 Winter Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Waltham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text"> 857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">399-9500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Voting Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TCRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M@IOWKS\C$#<EQ,UE$ LFN3!Y'A%8+;4\N)+-;IO>3?G=*]EZE\3MF6VYR7"
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M$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( .,Y95J7BKL<P
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( .,Y95H'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ XSEE6N,-
M^1+N    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ XSEE6IE<G",0!@  G"<  !,              ( !S $
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #C.65:ITWV$7$$  !$
M$0  &               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ XSEE6I^@&_"Q @  X@P   T              ( !M P
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #C.65:EXJ[',     3 @  "P
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52P4&      D "0 ^ @  %!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tcrx-20250305.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tcrx-20250305.htm">tcrx-20250305.htm</File>
    <File>tcrx-20250305.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tcrx-20250305.htm": {
   "nsprefix": "tcrx",
   "nsuri": "http://www.tscan.com/20250305",
   "dts": {
    "inline": {
     "local": [
      "tcrx-20250305.htm"
     ]
    },
    "schema": {
     "local": [
      "tcrx-20250305.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_7eb36c90-2bec-4080-b695-617c9e5c895d",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20250305.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7eb36c90-2bec-4080-b695-617c9e5c895d",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20250305.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.tscan.com/20250305/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-25-033071-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-033071-xbrl.zip
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MIYXX(M5K)&'I_-6?K(;OM4()3*EQG,::4HUO0:(34*6 :4WC-K%P<VVAT[H
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MA=&4W$@6".YED37YV1 73V5CO*VRED6=6?K DR<45""*,RT8F^M[&!0*"JI
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MF82*7'3RF:P_8P'&KO'M%7EP?$PQZ0K3IPF'SV,?&J?7+G@.-;"LIU "-CG
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MK+2\")ER83U+77S;RM<CW8NB*?>N;ICU%SJQ+,F!A1=L3WR57TT**VPFY?E
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M$0J)-?>1-;M6PW&.%+$[G^K$F\2;Q)M[R9L-J^=TCA2Q.Y_JF[V*\C!]9D>
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M E!+ 0(4 Q0    ( .,Y95I0910>010  %6U   1              "  0
M  !T8W)X+3(P,C4P,S U+FAT;5!+ 0(4 Q0    ( .,Y95I06:/WH0D  (-X
M   1              "  7 4  !T8W)X+3(P,C4P,S U+GAS9%!+ 0(4 Q0
M   ( .,Y95HSUDO$'RD  -OE @ /              "  4 >  !T8W)X+65X
>.3E?,2YH=&U02P4&      ,  P"[    C$<

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>tcrx-20250305_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tcrx-20250305.xsd" xlink:type="simple"/>
    <context id="C_7eb36c90-2bec-4080-b695-617c9e5c895d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <startDate>2025-03-05</startDate>
            <endDate>2025-03-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_d291a10e-2b1c-4ab9-b9cd-f845be9e0e90">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_93b02190-b0ff-4c56-8b69-93349406844e">0001783328</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_078e0e57-8ead-4855-8a52-d60536c1d642">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_80d9a5e0-e4b4-46cf-9753-2e4f51b70664">2025-03-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_09300625-4434-4b6a-aa7e-4afa8e034710">TSCAN THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_1bca718d-897d-4ef3-9635-70cb5c9dc232">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_6db9a875-c84a-4e2a-a899-662b4742106c">001-40603</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_15256d45-a01e-4e0d-a7fd-e071cedfdc84">82-5282075</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_1094ebb7-84a3-430a-b0cb-3e444acaad87">830 Winter Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_adf085f5-ea9b-419b-b3fa-d8708a9f533a">Waltham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_63f27d6e-16ac-4fd9-a5f6-12eb4b46a230">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_e0b14f39-dfac-43be-b7f5-4c739611a0c0">02451</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_5ac98563-bc87-427e-8fe1-6c3d4325fdee"> 857</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_2b385c80-b306-437c-b24b-0393dc0ebe21">399-9500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_c755d68b-1b9d-4a68-8901-d6df30ac6e9d">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_c759451f-6dfb-40be-b388-cd5301332e85">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_a483a9ef-0fe6-4a42-8353-59896ff717aa">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_8dca841a-ceb3-4807-957b-8e406bfcf40f">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_baa9cad6-e92c-4664-a9ec-fa0e9f11fb37">Voting Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_7c39a183-2a6a-471f-b138-20364eca7d56">TCRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_7770a869-77be-4fae-9559-389ef86fb4db">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_f0ca7d80-fe06-48b0-a83f-2f18a3f5d656">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_7eb36c90-2bec-4080-b695-617c9e5c895d"
      id="F_a2c1f37b-1e41-4806-93f6-81c72b5695dc">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
